scn8a encephalopathy
Showing 1 - 2 of 2
SCN2A Encephalopathy, SCN8A Encephalopathy Trial in Tacoma (Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks, Part A: 0.5mg/kg/day
Recruiting
- SCN2A Encephalopathy
- SCN8A Encephalopathy
- Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks
- +2 more
-
Tacoma, WashingtonPraxis Research Site
Apr 18, 2023
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023